SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-20-000067
Filing Date
2020-05-07
Accepted
2020-05-07 16:37:27
Documents
19
Effectiveness Date
2020-05-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A pdli-20200507defa14adoc.htm DEFA14A 44245
2 PRESS RELEASE pdli-202005078xkex991.htm EX-99.1 232269
3 PRESENTATION pdli-202005078xkex992b.htm EX-99.2 6843
4 pdllogoa33.jpg GRAPHIC 123123
5 slide1b24.jpg GRAPHIC 49912
6 slide2b23.jpg GRAPHIC 227111
7 slide3b23.jpg GRAPHIC 178458
8 slide4b23.jpg GRAPHIC 86096
9 slide5b23.jpg GRAPHIC 150197
10 slide6b23.jpg GRAPHIC 129769
11 slide7b23.jpg GRAPHIC 139493
12 slide8b21.jpg GRAPHIC 125308
13 slide9b20.jpg GRAPHIC 176526
14 slidy34.jpg GRAPHIC 87700
15 slidy35.jpg GRAPHIC 106971
16 slidy36.jpg GRAPHIC 149643
17 slidy37.jpg GRAPHIC 120339
18 slidy38.jpg GRAPHIC 109162
19 slidy39.jpg GRAPHIC 30982
  Complete submission text file 0000882104-20-000067.txt   3027539
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 20857072
SIC: 2836 Biological Products, (No Diagnostic Substances)